Drugs / tegafur-uracil
last change Feb 2024 re-read 8 days ago

tegafur-uracil

also known as UFT · fluorouracil-uracil · Uracil-tegafur

Small molecule

Developed for
colorectal cancer · head and neck cancer · malignant colon neoplasm · nasopharyngeal carcinoma · breast cancer · breast neoplasm · cancer of unknown primary site · hepatocellular carcinoma
+1 more · oral cavity squamous cell carcinoma
Investigated by
Mackay Memorial Hospital · National Cancer Institute (NCI) · Taichung Veterans General Hospital · Barbara Ann Karmanos Cancer Institute · Cancer Hospital of Guangxi Medical University · Centre Oscar Lambret
+25 more · Chang Gung Memorial Hospital · China Medical University Hospital · Department of breast and endocrine surgery graduate school of Medicine Osaka University · Egyptian Society of Liver Cancer · Eye & ENT Hospital of Fudan University · First Affiliated Hospital of Fujian Medical University · Fudan University · Jiangxi Provincial Cancer Hospital · Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung Veterans General Hospital. · Koo Foundation Sun Yat-Sen Cancer Center · Memorial Sloan Kettering Cancer Center · National Cancer Centre, Singapore · National Cheng-Kung University Hospital · National Health Research Institutes, Taiwan · National Taiwan University Hospital · Northwestern University · Peking University Cancer Hospital & Institute · People's Hospital of Guangxi Zhuang Autonomous Region · Shanghai Proton and Heavy Ion Center · The First Affiliated Hospital of Xiamen University · Tongji Hospital · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · West China Hospital · Yokohama City University

Trials 13

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT00003925 May 1998 → Aug 2007 cancer of unknown primary site Barbara Ann Karmanos Cancer Institute Completed No outcome recorded
Phase 1 NCT00002801 Apr 1996 → Dec 2003 colorectal cancer Memorial Sloan Kettering Cancer Center Completed No outcome recorded
Phase 25 trials
Phase 2 NCT03121313 Feb 2015 → May 2020 oral cavity squamous cell carcinoma Chang Gung Memorial Hospital Unknown No outcome recorded
Phase 2 NCT01539018 Jan 2012 → Jan 2015 hepatocellular carcinoma Egyptian Society of Liver Cancer Terminated No outcome recorded
Phase 2 NCT01262274 Dec 2010 → Jun 2013 breast neoplasm Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan Terminated No outcome recorded
Phase 2 NCT00855881 Dec 2008 → Dec 2014 head and neck cancer Mackay Memorial Hospital Unknown No outcome recorded
Phase 2 NCT00005608 Feb 2000 → Jun 2002 breast cancer Northwestern University Terminated No outcome recorded
Phase 34 trials · 1 missed
Phase 3 NCT02944708 Oct 2015 → Oct 2018 nasopharyngeal carcinoma Shanghai Proton and Heavy Ion Center Unknown No outcome recorded
Phase 3 NCT02363400 Dec 2014 → Dec 2021 nasopharyngeal carcinoma National Health Research Institutes, Taiwan Terminated No outcome recorded Stop: Enrollment
Phase 3 NCT00336947 Apr 2006 → Mar 2012 head and neck cancer Yokohama City University Unknown Missed primary
Phase 3 NCT00905047 Nov 2005 → Jun 2010 colorectal cancer Centre Oscar Lambret Completed No outcome recorded
Phase 41 trial
Phase 4 NCT02887365 Sep 2014 → Aug 2017 malignant colon neoplasm National Taiwan University Hospital Unknown No outcome recorded
Phase not applicable1 trial
— NCT02836977 Mar 2016 → Mar 2017 malignant colon neoplasm Kaohsiung Medical University Chung-Ho Memorial Hospital Unknown No outcome recorded
Comparator or background therapy6 trials
Phase 1 NCT00009828 Background Dec 1999 → ? cancer of unknown primary site University of Pittsburgh Withdrawn No outcome recorded
Phase 1 NCT00009815 Background Dec 1999 → ? cancer of unknown primary site University of Pittsburgh Withdrawn No outcome recorded
Phase 2 NCT02447679 Background Aug 2010 → Jan 2017 adult hepatocellular carcinoma, hypersensitivity reaction disease, perifoveal exudative vascular anomalous complex Chang Gung Memorial Hospital Completed No outcome recorded
Phase 3 NCT00660894 Comparator Apr 2008 → Jun 2012 colorectal cancer Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan Completed Met primary
Phase 3 NCT00392899 Comparator Oct 2006 → Oct 2015 colorectal cancer Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 20 sources stand behind the page.

FieldValueCited text
Known as TEGAFUR URACIL “Maintenance chemotherapy should use one of the regimens: S1 (40mg, twice a day for 14 days, every 3 weeks), capecitabine (1000mg/m\^2, twice a day for 14 days, every 3 weeks)...” NCT02944708 ↗
20

“The SACURA trial is a randomised-controlled study evaluating the superiority of 1-year adjuvant treatment with oral tegafur-uracil (UFT) to surgery alone for stage II colon cancer.” PMID 29677641 ↗ Apr 2018

“Tegafur/uracil treatment of mice with RENCA tumors has been shown to inhibit angiogenesis, leading to a significant prolongation of life span.” NCT00855881 ↗

“Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer” NCT00905047 ↗

“Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer” NCT00905047 ↗

“oral Tegafur-uracil” NCT02363400 ↗

NCT01262274 ↗

NCT00660894 ↗

NCT00336947 ↗

NCT00009815 ↗

NCT00003925 ↗

Show 10 more sources

Known as fluorouracil-uracil “This is a dose-escalation study of fluorouracil-uracil (UFT).” NCT00002801 ↗
Known as UFT “Uracil-tegafur (UFT), an oral fluoropyrimidine prodrug, is available commercially in Japan and in several other countries.” NCT00855881 ↗
7

“Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer” NCT00905047 ↗

“Patients receive oral tegafur-uracil (UFT) once daily on days 1-21.” NCT00336947 ↗

“This is a dose-escalation study of fluorouracil-uracil (UFT).” NCT00002801 ↗

“metronomic tegafur-uracil (UFT)” NCT01262274 ↗

“Why Tegafur-uracil (UFT)?” NCT01539018 ↗

“Tegafur-uracil (UFT)” NCT00385970 ↗

NCT00392899 ↗

Known as Uracil-tegafur “Uracil-tegafur (UFT), an oral fluoropyrimidine prodrug, is available commercially in Japan and in several other countries.” NCT00855881 ↗
Action Inhibit “The 5-FU metabolite FdUMP binds and inhibits the enzymatic activity of thymidylate synthase (TS)” NCT00855881 ↗
Modality Small molecule “an oral fluoropyrimidine prodrug” NCT00855881 ↗
Route Oral “patients receive oral UFT and oral leucovorin calcium (CF) 3 times a day on days 1-28.” NCT00002801 ↗